Latest Breaking News On - Advancing oncology - Page 4 : comparemela.com

LUMAKRAS® (SOTORASIB) RECEIVES APPROVAL IN JAPAN FOR PATIENTS WITH KRAS G12C-MUTATED ADVANCED NON-SMALL CELL LUNG CANCER

THOUSAND OAKS, Calif., Jan. 20, 2022 /PRNewswire/ Amgen (NASDAQ: AMGN) today announced that LUMAKRAS® (sotorasib) has been approved in Japan fo.

United statesHong kongUnited kingdomSaudi arabia generalSaudi arabiaUnited arab emiratesPuerto ricoMinistry of healthSouth koreaGreat britainMichael strapazonSteve suginoMegan foxAstellas pharmaAmgen astellas biopharmaSpira al

EUROPEAN COMMISSION APPROVES LUMYKRAS® (SOTORASIB) FOR PATIENTS WITH KRAS G12C-MUTATED ADVANCED NON-SMALL CELL LUNG CANCER

/PRNewswire/ Amgen (NASDAQ: AMGN) today announced that the European Commission (EC) has granted conditional marketing authorization for LUMYKRAS®.

United statesHong kongUnited kingdomUnited arab emiratesPuerto ricoSaudi arabiaSouth koreaGreat britainMichael strapazonMegan foxSpira alDavidm reeseKyowa kirin co ltdEuropean commissionWorld health organizationBeigene ltd

EUROPEAN COMMISSION APPROVES LUMYKRAS® (SOTORASIB) FOR PATIENTS WITH KRAS G12C-MUTATED ADVANCED NON-SMALL CELL LUNG CANCER

/PRNewswire/ Amgen (NASDAQ: AMGN) today announced that the European Commission (EC) has granted conditional marketing authorization for LUMYKRAS®.

United statesHong kongUnited kingdomUnited arab emiratesPuerto ricoSaudi arabiaSouth koreaGreat britainMichael strapazonMegan foxSpira alDavidm reeseKyowa kirin co ltdEuropean commissionWorld health organizationBeigene ltd

EUROPEAN COMMISSION APPROVES LUMYKRAS® (SOTORASIB) FOR PATIENTS WITH KRAS G12C-MUTATED ADVANCED NON-SMALL CELL LUNG CANCER

EUROPEAN COMMISSION APPROVES LUMYKRAS® (SOTORASIB) FOR PATIENTS WITH KRAS G12C-MUTATED ADVANCED NON-SMALL CELL LUNG CANCER
morningstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morningstar.com Daily Mail and Mail on Sunday newspapers.

United statesHong kongUnited kingdomUnited arab emiratesPuerto ricoSaudi arabiaSouth koreaGreat britainMichael strapazonMegan foxSpira alDavidm reeseKyowa kirin co ltdC clinical development programEuropean commissionWorld health organization